Franklin Resources Inc Metacrine, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.64 - $3.83 $232,704 - $1.39 Million	-363,600 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.61 - $3.84 $2.47 Million - $3.63 Million	-945,457 Reduced 72.22%	363,600 $1.25 Million
Q4 2020 Feb 10, 2021	BUY	$7.75 - $11.42 $5.38 Million - $7.92 Million	693,673 Added 112.72%	1,309,057 $10.3 Million
Q3 2020 Nov 12, 2020	BUY	$9.38 - $11.76 $5.77 Million - $7.24 Million	615,384 New	615,384 $6.25 Million

Ticker MTCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,569,500
Description
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.